HUNTINGTON’S DISEASE: CURRENT ADVANCES AND FUTURE PROSPECTS

  • N. B
  • RAMANATHAN A
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Huntington’s disease is a neurodegenerative disease which is caused by dominantly inherited cytosine-adenine-guanine trinucleotide repeat expansion in the huntingtin gene of chromosome 4. Present survey reveals 2.7 per 100000 people are affected by huntington’s disease worldwide. The symptoms present with these patients are progressive motor, cognitive and psychiatric disorders. The early symptoms are chorea and loss of balance. This review aims to observe the present data available concerning huntington’s disease, symptoms, age of onset, risk factors, benefits of early diagnosis and genetic attribution. There is no cure for the disease. The article searched, selected and reviewed were from google scholar, medscape, NIH MedlinePlus, PubMed database using MeSH terms huntington’s disease, recent therapeutic advancement from 2003 to July 2021 with no language restriction and additional studies were included from the reference lists of relevant articles. The present review provides clinical features, diagnosis, symptomatic management and ongoing research. Hence this review will have an impact to create awareness for the society and researchers to find future treatment for Huntington’s disease.

Cite

CITATION STYLE

APA

N., B. L. J., & RAMANATHAN, A. (2021). HUNTINGTON’S DISEASE: CURRENT ADVANCES AND FUTURE PROSPECTS. International Journal of Pharmacy and Pharmaceutical Sciences, 9–14. https://doi.org/10.22159/ijpps.2021v13i12.42979

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free